Compare Stocks → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ALSEOTCMKTS:AXMPOTCMKTS:BOPHOTCMKTS:MTSTOTCMKTS:OREXQ Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALSEAlseres Pharmaceuticals$0.01$0.01$0.01▼$0.01N/A0.11N/AN/AAXMPAXM Pharma$0.00$0.00▼$0.00N/AN/AN/AN/ABOPHBohai Pharmaceuticals Group$0.00$0.00$0.00▼$0.00$20K1.7830,425 shs50,000 shsMTSTMetaStat$0.00$0.00▼$0.08N/AN/AN/AN/AOREXQOrexigen Therapeutics$0.01+35.9%$0.01$0.00▼$0.16$100K4.9880,439 shs60,300 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALSEAlseres Pharmaceuticals0.00%0.00%0.00%0.00%-50.00%AXMPAXM Pharma0.00%0.00%0.00%0.00%0.00%BOPHBohai Pharmaceuticals Group0.00%0.00%0.00%0.00%0.00%MTSTMetaStat0.00%0.00%0.00%0.00%0.00%OREXQOrexigen Therapeutics0.00%0.00%0.00%0.00%0.00%Top Project Outperforms BTC in 2023… (Ad)According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALSEAlseres PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAXMPAXM PharmaN/AN/AN/AN/AN/AN/AN/AN/ABOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/AN/AN/AN/AMTSTMetaStatN/AN/AN/AN/AN/AN/AN/AN/AOREXQOrexigen TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALSEAlseres PharmaceuticalsN/AN/AN/AN/AAXMPAXM PharmaN/AN/AN/AN/ABOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AMTSTMetaStatN/AN/AN/AN/AOREXQOrexigen TherapeuticsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALSEAlseres PharmaceuticalsN/AN/AN/AN/AN/AN/AAXMPAXM PharmaN/AN/AN/AN/AN/AN/ABOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/AN/AMTSTMetaStatN/AN/AN/AN/AN/AN/AOREXQOrexigen Therapeutics$33.71M0.00N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALSEAlseres PharmaceuticalsN/AN/A0.00∞N/AN/AN/AN/AN/AAXMPAXM PharmaN/AN/A0.00N/AN/AN/AN/AN/AN/ABOPHBohai Pharmaceuticals GroupN/AN/A0.00∞N/AN/AN/AN/AN/AMTSTMetaStatN/AN/A0.00N/AN/AN/AN/AN/AN/AOREXQOrexigen Therapeutics-$24.52MN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALSEAlseres PharmaceuticalsN/AN/AN/AN/AN/AAXMPAXM PharmaN/AN/AN/AN/AN/ABOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/AMTSTMetaStatN/AN/AN/AN/AN/AOREXQOrexigen TherapeuticsN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipALSEAlseres PharmaceuticalsN/AAXMPAXM PharmaN/ABOPHBohai Pharmaceuticals GroupN/AMTSTMetaStatN/AOREXQOrexigen TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipALSEAlseres Pharmaceuticals8.94%AXMPAXM Pharma38.65%BOPHBohai Pharmaceuticals GroupN/AMTSTMetaStat8.50%OREXQOrexigen Therapeutics13.30%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALSEAlseres Pharmaceuticals3N/AN/ANot OptionableAXMPAXM Pharma150N/AN/ANot OptionableBOPHBohai Pharmaceuticals GroupN/A19.52 millionN/ANot OptionableMTSTMetaStat6N/AN/ANot OptionableOREXQOrexigen TherapeuticsN/A18.89 millionN/ANot OptionableAXMP, MTST, OREXQ, ALSE, and BOPH HeadlinesSourceHeadlineAxsome Therapeutics Inc (AXSM)investing.com - February 2 at 5:42 AMHeron Therapeutics Inc HRTXmorningstar.com - November 4 at 7:15 PMNovel Therapeutics and Targets for the Treatment of Diabetesmedscape.com - April 15 at 8:02 AMRegulation of Appetite to Treat Obesitymedscape.com - March 30 at 12:13 AMOrexigen Therapeutics (OREX) Stock Climbs on $60 Million Investmentthestreet.com - February 19 at 9:20 AMOrexigen Therapeutics (OREX) Stock Declines After Halting Heart Benefit Teststhestreet.com - January 18 at 7:29 PMWall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bromarkets.businessinsider.com - November 5 at 2:18 PMMedia Sentiment Over TimeCompany DescriptionsAlseres PharmaceuticalsOTCMKTS:ALSEAlseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.AXM PharmaOTCMKTS:AXMPAXM Pharma, Inc. manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China. The company is based in New York, New York.Bohai Pharmaceuticals GroupOTCMKTS:BOPHBohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.MetaStatOTCMKTS:MTSTMetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients. The MenaCalc, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is broadly applicable in solid epithelial-based cancers, including breast, prostate, lung and colorectal. The company was founded by Warren C. Lau in July 2009 and is headquartered in Boston, MA.Orexigen TherapeuticsOTCMKTS:OREXQOrexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.